Dabur Research Foundation
Dabur Research Foundation (DRF) is a premier Indian Contract Research Organization established in 1979, offering comprehensive preclinical services in drug discovery and development. With over 30 years of expertise, DRF specializes in in vitro, ex vivo, and in vivo pharmacology, toxicology, DMPK, genotoxicity, and other preclinical studies. It serves the global biotech, pharma, phytopharmaceuticals, cosmeceuticals, and academic sectors. The organization aims to be the leading preclinical CRO in India, committed to quality, innovation, and strategic partnerships, supporting healthcare advancements worldwide.
Industries
Nr. of Employees
medium (51-250)
Dabur Research Foundation
22, Site IV, Sahibabad Ghaziabad, Uttar Pradesh, India
Products
Nutraceutical formulations for lifestyle disease management
Development and testing support for nutraceutical product formulations intended for metabolic and lifestyle disease management (examples described as capsule formats for lipid, glycemic and stress support).
Topical nanotechnology product prototypes
Topical product formats developed using nanoscale delivery (examples include pain relief creams/roll‑ons, anti‑aging and skin creams) and ingestible nanoscale formats adapted to commercial dosage forms.
Synbiotic (probiotic + prebiotic) formulations — granulated powder and capsule
Development, characterization and evaluation of synbiotic products formulated as granulated powder and capsules, with stability and quality assessment performed under ICH‑aligned practices.
Nutraceutical formulations for lifestyle disease management
Development and testing support for nutraceutical product formulations intended for metabolic and lifestyle disease management (examples described as capsule formats for lipid, glycemic and stress support).
Topical nanotechnology product prototypes
Topical product formats developed using nanoscale delivery (examples include pain relief creams/roll‑ons, anti‑aging and skin creams) and ingestible nanoscale formats adapted to commercial dosage forms.
Synbiotic (probiotic + prebiotic) formulations — granulated powder and capsule
Development, characterization and evaluation of synbiotic products formulated as granulated powder and capsules, with stability and quality assessment performed under ICH‑aligned practices.
Services
In vitro, ex‑vivo and in vivo pharmacology services across oncology, immunopathology, metabolic and endocrine disorders, neurology, dermatology, regenerative medicine, ophthalmology and cellular aging.
GLP and non‑GLP toxicology, genotoxicity, reproductive/developmental toxicity and in‑vitro safety testing to support regulatory submissions.
Pharmacokinetics, tissue distribution and bioanalytical quantification for small molecules and formulations using validated LC‑MS/MS and related methods.
In vitro antimicrobial susceptibility testing, viral cytopathic and virucidal assays, spike–receptor interaction screening, cytokine modulation assays and in vivo antiviral efficacy models.
Analytical method development, forced degradation, fingerprinting, marker identification, stability and validation using chromatography and mass spectrometry for drug, herbal and agrochemical matrices.
Regulatory testing and 5‑batch impurity/active ingredient analysis for agrochemical registration including validated analytical method support and impurity identification.
In vitro, ex‑vivo and in vivo pharmacology services across oncology, immunopathology, metabolic and endocrine disorders, neurology, dermatology, regenerative medicine, ophthalmology and cellular aging.
GLP and non‑GLP toxicology, genotoxicity, reproductive/developmental toxicity and in‑vitro safety testing to support regulatory submissions.
Pharmacokinetics, tissue distribution and bioanalytical quantification for small molecules and formulations using validated LC‑MS/MS and related methods.
In vitro antimicrobial susceptibility testing, viral cytopathic and virucidal assays, spike–receptor interaction screening, cytokine modulation assays and in vivo antiviral efficacy models.
Analytical method development, forced degradation, fingerprinting, marker identification, stability and validation using chromatography and mass spectrometry for drug, herbal and agrochemical matrices.
Regulatory testing and 5‑batch impurity/active ingredient analysis for agrochemical registration including validated analytical method support and impurity identification.
Expertise Areas
- Preclinical CRO services
- In vitro and in vivo pharmacology
- GLP toxicology and regulatory safety assessment
- DMPK and tissue distribution analysis
Key Technologies
- LC‑MS/MS bioanalysis
- HPLC / UHPLC
- GC / GC‑MS/MS
- ICP‑MS and ion chromatography
News & Updates
The article discusses drug repurposing as a strategic approach in drug discovery, emphasizing its efficiency, cost-effectiveness, and potential to address unmet medical needs.
This blog explores neuropharmacology, focusing on mental and behavioral health issues, and the advanced research facilities at DRF for neuropharmacology studies.
The article covers lifestyle diseases linked to daily habits and the role of aromatherapy in managing health, along with DRF's innovations in natural skincare and nutraceuticals.
This blog discusses methodologies for quantifying analytes in tumor samples using LC-MS/MS, crucial for accurate dosing and understanding drug distribution in cancer treatment.
The article discusses drug repurposing as a strategic approach in drug discovery, emphasizing its efficiency, cost-effectiveness, and potential to address unmet medical needs.
This blog explores neuropharmacology, focusing on mental and behavioral health issues, and the advanced research facilities at DRF for neuropharmacology studies.
The article covers lifestyle diseases linked to daily habits and the role of aromatherapy in managing health, along with DRF's innovations in natural skincare and nutraceuticals.
This blog discusses methodologies for quantifying analytes in tumor samples using LC-MS/MS, crucial for accurate dosing and understanding drug distribution in cancer treatment.